QUVIVIQ Trademark

Trademark Overview


On Thursday, October 8, 2020, a trademark application was filed for QUVIVIQ with the United States Patent and Trademark Office. The USPTO has given the QUVIVIQ trademark a serial number of 79299719. The federal status of this trademark filing is REGISTERED as of Tuesday, August 24, 2021. This trademark is owned by Idorsia Pharmaceuticals Ltd. The QUVIVIQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for humans for the prevention and treatment of cardiovascular diseases, hypertension, brain haemorrhage and sequelae thereof, kidney diseases, pulmonary diseases, fibrotic diseases, cystic fibrosis, inflammatory diseases, allergic diseases, auto-immune diseases and disorders, neurodegenerative diseases and disorders, neurological diseases and disorders, diseases and disorders of the central nervous system, dementia, sleep disorders, anxiety disorders, addictions, eating disorders, epilepsy, metabolic disorders, diabetes, glycolipid storage disorders, Fabry disease and symptoms and sequelae of Fabry disease, infectious diseases, and cancer
quviviq

General Information


Serial Number79299719
Word MarkQUVIVIQ
Filing DateThursday, October 8, 2020
Status700 - REGISTERED
Status DateTuesday, August 24, 2021
Registration Number6458380
Registration DateTuesday, August 24, 2021
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 8, 2021

Trademark Statements


Description of MarkThe mark consists of the stylized wording "QUVIVIQ" with a shaded triangle appearing under the letters "VIV".
Goods and ServicesPharmaceutical preparations for humans for the prevention and treatment of cardiovascular diseases, hypertension, brain haemorrhage and sequelae thereof, kidney diseases, pulmonary diseases, fibrotic diseases, cystic fibrosis, inflammatory diseases, allergic diseases, auto-immune diseases and disorders, neurodegenerative diseases and disorders, neurological diseases and disorders, diseases and disorders of the central nervous system, dementia, sleep disorders, anxiety disorders, addictions, eating disorders, epilepsy, metabolic disorders, diabetes, glycolipid storage disorders, Fabry disease and symptoms and sequelae of Fabry disease, infectious diseases, and cancer

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, December 14, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIdorsia Pharmaceuticals Ltd
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameIdorsia Pharmaceuticals Ltd
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameIdorsia Pharmaceuticals Ltd
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Monday, February 28, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, February 8, 2022FINAL DISPOSITION NOTICE SENT TO IB
Tuesday, February 8, 2022FINAL DISPOSITION PROCESSED
Wednesday, November 24, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 24, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, June 8, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 8, 2021PUBLISHED FOR OPPOSITION
Wednesday, May 19, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 5, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 27, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 27, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 27, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 27, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, April 27, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, April 27, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, April 27, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, April 27, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 27, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 5, 2021REFUSAL PROCESSED BY IB
Thursday, March 18, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, March 18, 2021REFUSAL PROCESSED BY MPU
Tuesday, March 16, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, March 15, 2021NON-FINAL ACTION WRITTEN
Monday, March 8, 2021ASSIGNED TO EXAMINER
Friday, December 18, 2020APPLICATION FILING RECEIPT MAILED
Monday, December 14, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, December 10, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB